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flect Job' s mutations. Constructs were cotransfected into a STAT3
deficient cell line (Cos1) as well as a cell line with endogenous
STAT3 (HeLa) along with a STAT3-responsive luciferase reporter
vector. Peripheral blood mononuclear cells (PBMCs) from Job' s pa-
tients were used to measure STAT3 activation in nuclear extracts
by STAT3 binding to DNA in an ELISA assay. NFκB nuclear translo-
cation was detected with confocal microscopy using antibodies to
p65 and p50. p38 MAP kinase activity was measured by ELISA. De-
phosphorylation of STAT3 was examined by immunoblot.
Results: Mutations within both the DNA binding and SH2 domains
result in loss-of-function but are dominant negative. Mutant con-
structs in Cos-1 cells did not transactivate the STAT3 reporter and
transfection in HeLa cells resulted in a decrease of luciferase ac-
tivity by 80-84% as compared with wild type after stimulation with
oncostatin M. Cotransfection of wild type and mutant constructs
together in Cos-1 cells resulted in 24-63% loss of activity. IL10 plus
lipopolysaccharide (LPS) stimulation of PBMCs from Job' s patients
resulted in a 14-fold decrease in STAT3 activity as compared to
normals as measured by ELISA. Following LPS stimulation, p38 MAP
kinase phosphorylation between normal and Job' s cells were com-
parable, but NFκB activity was higher in Job' s cells. Dephosphory-
lation of STAT3 was normal in PBMCs from Job' s patients following
treatment with staurosporine.
Conclusions: Job' s STAT3 mutations act in a dominant negative
manner. Both DNA binding and SH2 mutations decrease activation
of STAT3 in response to several stimuli impairing downstream sig-
naling. These methods to evaluate the function of STAT3 mutants
will help dissect mechanisms of STAT3 control of susceptibility to
infection and control of inflammation.
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Introduction: X-linked chronic granulomatous disease (CGD) is
caused by mutations in the CYBB gene, which impair gp91phox
function and therefore lead to deficient superoxide generation
by the phagocyte NADPH oxidase system. This leads to defective
killing of certain bacteria and fungi and results in severe infections
and granuloma formation.
Case: A 20-year-old man with X-linked CGD had a long history
of classic CGD and severe inflammatory bowel disease requiring
colonic diversion. He had two distinct populations of neutrophils
by neutrophil oxidative burst testing of peripheral blood. In
two independent measurements of neutrophil oxidative burst by
dihydrorhodamine (DHR) assay, 97% of peripheral blood neutrophils
failed to oxidize dihydrorhodamine (DHR-), while 3% had a normal
oxidative capacity (DHR+). Sorted DHR+ and DHR- cells were stud-
ied by microsatellite analyses, which proved patient origin of both
the DHR+ and DHR- cells. The DHR- cells and buccal mucosal ep-
ithelial cells and unsorted peripheral blood mononuclear cells had
the mutation 676C>T, which causes a premature stop (R226X) in
CYBB. In contrast, the DHR+ cells had the wild-type sequence, 676C
leading to a normal protein. Therefore, since he had the majority
of his peripheral blood and his buccal cells mutant, and only a small
percentage reverted to normal, we believe that he has reverted
the mutation in a small population of his neutrophil precursors. Ex-
ploration of other cell lines (lymphoid, monocyte, etc) is underway.
Discussion: Somatic mosaicism due to site-specific reversions of
inherited mutations to wild type has been described in other im-
munodeficiencies and has been linked to milder disease in some
cases. This is the first report of a reversion mutation in X-linked
CGD, and the only report of a reversion mutation affecting neu-
trophils in a primary phagocyte defect. Reversion mutations can
occur in neutrophils, just as they do in lymphocytes and may be
more common than previously thought.
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Background: Autosomal dominant hyper-IgE syndrome (AD-HIES,
Job' s syndrome) is a primary immunodeficiency characterized by
recurrent staphylococcal abscesses, pneumonia, eczema, and el-
evated serum IgE. Connective tissue defects are also frequent.
AD-HIES results from heterozygous hypomorphic mutations in the
STAT3 gene, primarily affecting either the SH2 or DNA-binding do-
mains. Filamentous fungal pneumonias (FFP), particularly with As-
pergillus spp., have been reported in patients with clinically sus-
pected AD-HIES. However, these reports pre-dated the ability to
genotypically confirm the patients' diagnoses and have been lim-
ited in sample size, precluding comprehensive understanding of
this infection in AD-HIES. We sought to determine the prevalence
of FFP in a large cohort of patients with confirmed AD-HIES.
Methods: Retrospective chart review of all AD-HIES patients fol-
lowed at the NIH, for which the diagnosis was confirmed by genetic
sequencing.
Results: 56 AD-HIES patients with STAT3 mutations were identi-
fied: 22 (39.3%) had no radiological evidence of lung cysts (includes
cavities, pneumatoceles), while 34 (60.7%) did. Among those with-
out cysts, none (0%) developed FFP. Among those with lung cysts,
13 (38.2%) developed FFP. Aspergillus/Neosartorya spp. were most
common (11 total, 84.6%); infection with S. apiospermum (n=1)
and H. capsulatum (n=1) also occurred. Multiple episodes of FFP
frequently occurred in affected patients and did not occur exclu-
sively in pre-existing cysts. Patients were stratified based on their
mutation (SH2, n=28; DNA, n=28). Lung cysts were equally fre-
quent in each group (n=17 for both). The number of patients in
each group with lung cysts developing FFP was similar (SH2: 7/17
(41.2%); DNA: 6/17 (35.3%)) as was the median age at onset of
1st FFP (SH2: 30.5 yrs; DNA: 35.5 yrs). Treatment modalities var-
ied and included antifungal agents (systemic, occasionally adjunc-
tive intra-cavitary) with or without surgical resection. Mortality
occurred more frequently in the DNA group (3/6; 50%) than in the
SH2 group (0/7; 0%).
Conclusions: Patients with AD-HIES with lung cysts are at signifi-
cantly increased risk for FFP, typically in their third decade of life.
FFP do not necessarily occur only in pre-existing cysts/cavities,
suggesting that cysts/cavities may be a marker for susceptibility
rather than a cause of the infection. Aspergillus spp. are the pri-
mary pathogens. The mortality rate is significant and possibly re-
lated to genotype.
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Background: Two Qatari sisters (5 and 12 yrs.) with a family his-
tory of consanguinity (parents are first cousins) and suspected neu-
trophil dysfunction had frequent severe skin and mucosal ulcera-
